|
Re: How I See It
|
5
|
Resverlogix Corp.
|
May 04, 2016 04:33PM
|
|
Re: ... unfinished business
|
5
|
Zenith Epigenetics
|
Nov 02, 2018 06:00PM
|
|
Re: reverse split
|
5
|
Resverlogix Corp.
|
Sep 12, 2018 07:02PM
|
|
Re: Protecting shares from being borrowed by shorts
|
5
|
Resverlogix Corp.
|
May 18, 2018 12:11PM
|
|
Re: Explanation?
|
5
|
Resverlogix Corp.
|
Oct 05, 2017 07:55PM
|
|
Re: Rules on Disclosure
|
5
|
Resverlogix Corp.
|
Sep 26, 2019 10:29PM
|
|
New Interim Financials and MD&A docs on SEDAR
|
5
|
Resverlogix Corp.
|
Dec 16, 2015 10:45AM
|
|
Re: Trial
|
5
|
Zenith Epigenetics
|
Sep 19, 2016 12:38PM
|
|
Equity offering
|
5
|
Zenith Epigenetics
|
Jun 04, 2018 04:39PM
|
|
Israel Patent Application
|
5
|
Resverlogix Corp.
|
Jan 10, 2018 08:49AM
|
|
OncLive article mentioning ZEN-3694
|
5
|
Zenith Epigenetics
|
Jun 15, 2018 07:02PM
|
|
Beacon reiterates assessment
|
5
|
Resverlogix Corp.
|
Dec 20, 2017 07:38PM
|
|
Re: Volume almost 100,000 at 11am
|
5
|
Resverlogix Corp.
|
Mar 13, 2019 11:38AM
|
|
Pfizer's PCSK9 Inhibitor bococizumab - further development being scrapped
|
5
|
Resverlogix Corp.
|
Nov 01, 2016 11:17AM
|
|
New shares issued?
|
5
|
Zenith Epigenetics
|
Aug 07, 2018 08:36AM
|
|
Phase III - Where will it take place
|
4
|
Resverlogix Corp.
|
Sep 07, 2015 06:14PM
|
|
Novartis' canakinumab (Ilaris)
|
4
|
Resverlogix Corp.
|
Mar 13, 2018 01:32PM
|
|
Re: Warrants at $2....
|
4
|
Resverlogix Corp.
|
Aug 07, 2018 01:45PM
|
|
Re: Zenith AGM - Q&A
|
4
|
Zenith Epigenetics
|
Dec 19, 2017 01:09PM
|
|
Re: Tensha Therapeutics sold to Roche
|
4
|
Zenith Epigenetics
|
Jan 12, 2016 03:08PM
|
